MOTS-c humanin research explained: how these two mitochondrial-derived peptides differ, what studies show, and why neither is FDA-approved for human use.
MOTS-c and humanin are both mitochondrial-derived peptides (MDPs) — short signaling molecules encoded by DNA inside the mitochondria rather than the cell nucleus. Humanin is a 24-amino-acid peptide studied mainly for cell survival and neuroprotection, while MOTS-c is a 16-amino-acid peptide best known for regulating insulin sensitivity and cellular energy metabolism. Neither is FDA-approved for human use in the United States, and both are sold as research chemicals for laboratory study only.
What Is Humanin?
Humanin was identified in 2001 by researchers studying Alzheimer's disease. The peptide appeared to shield neurons from amyloid-beta toxicity, which is where its name comes from. It is encoded within the mitochondrial 16S rRNA gene (MT-RNR2) and can be measured in human blood.
Main research areas include:
- Cell survival: humanin blocks apoptosis triggered by oxidative and metabolic stress.
- Metabolic signaling: animal studies link humanin to improved insulin sensitivity and glucose handling.
- Inflammation: early data suggest it may influence inflammatory pathways.
- Analogs: Humanin-G (S14G-HN) is a synthetic variant widely used in lab work because it is more stable than the native peptide.
Human clinical data on humanin remain limited. Most findings come from cell cultures and rodent models, so claims about benefits in people are still speculative.
What Is MOTS-c?
MOTS-c stands for "mitochondrial open reading frame of the 12S rRNA-c." It was described in 2015 by researchers at the University of Southern California and is encoded in the mitochondrial 12S rRNA gene (MT-RNR1). The peptide is 16 amino acids long and circulates in plasma.
MOTS-c works as a metabolic signal. It activates AMPK, often described as the cell's energy sensor, and promotes glucose uptake in muscle tissue. Exercise raises MOTS-c levels, which is why it is sometimes called an "exercise mimetic." Rodent studies report improved insulin sensitivity and shifts in fat mass, but human trial evidence is much thinner — only an analog has been evaluated in early-phase clinical research.
How MOTS-c and Humanin Are Alike
Researchers studying humanin and mots-c usually treat them as two branches of the same field. Both peptides:
- Are encoded by mitochondrial DNA instead of nuclear DNA.
- Circulate in the bloodstream, with levels that decline with age in some studies.
- Act as stress-response signals that help cells adapt to metabolic pressure.
- Are investigated in the context of aging, insulin resistance, and age-related disease.
- Are sold for research use only, not as approved medicines.
Key Differences Between MOTS-c and Humanin
| Feature | MOTS-c | Humanin |
|---|---|---|
| Length | 16 amino acids | 24 amino acids |
| Genetic origin | MT-RNR1 (12S rRNA) | MT-RNR2 (16S rRNA) |
| First described | 2015 | 2001 |
| Primary research focus | Insulin sensitivity, AMPK signaling, energy metabolism | Neuroprotection, cell survival, apoptosis |
| Notable mechanism | AMPK activation; folate and purine metabolism | CNTF receptor complex (CNTFR / WSX-1 / gp130) |
| Common research analog | CB4211 | Humanin-G (S14G-HN) |
| FDA approval | None | None |
The practical takeaway: MOTS-c is studied mainly as a metabolic and exercise-related signal, while humanin is studied mainly as a cell-survival peptide. They overlap in aging research, but they are not interchangeable.
How They Compare With Other Metabolic Peptides
MOTS-c and humanin often come up in the same conversation as AOD-9604, tesamorelin, and SS-31. These are different classes of molecules with different mechanisms, and treating them as equivalents leads to bad conclusions.
- AOD-9604 is a fragment of human growth hormone (hGH 176-191) studied for fat metabolism. A direct aod 9604 vs mots-c comparison is not apples-to-apples: AOD-9604 works through growth hormone pathways, while MOTS-c acts on cellular energy sensing.
- Tesamorelin is a growth hormone-releasing hormone analog and is FDA-approved as Egrifta for HIV-associated lipodystrophy — the only compound in this group with an approved human indication.
- SS-31 (elamipretide) is a mitochondria-targeted tetrapeptide that binds cardiolipin on the inner mitochondrial membrane. It is not a mitochondrial-derived peptide, so a ss-31 and mots-c protocol would address membrane integrity and metabolic signaling — two separate things.
Combination use is where the evidence gets thinnest. No published human trial has tested an aod-9604 mots-c tesamorelin stack, and there is no reliable data on how these compounds interact in people.
Safety, Legal Status, and What to Know
MOTS-c and humanin are not approved drugs anywhere. In the United States they are sold as research chemicals labeled "not for human consumption," which means no regulator oversees their purity, identity, or sterility.
- Human safety data for MOTS-c are limited; most evidence comes from rodents and cell studies.
- Long-term safety of humanin in humans is unknown.
- Peptides sold online may be mislabeled, underdosed, or contaminated.
- There is no established aod 9604 mots-c tesamorelin dosage, so any specific number circulating online should be treated as unverified.
- Anyone considering these compounds should speak with a licensed healthcare professional first.
The Bottom Line
MOTS-c and humanin are mitochondrial-derived peptides with genuine laboratory research behind them and very little human clinical evidence. Humanin is studied for cell survival and neuroprotection; MOTS-c is studied for metabolic regulation and insulin sensitivity. Neither is FDA-approved, neither is a proven treatment for any condition, and stacking them with compounds like AOD-9604, tesamorelin, or SS-31 is unsupported by human data.
Frequently Asked Questions
What is the difference between MOTS-c and humanin?
MOTS-c is a 16-amino-acid peptide encoded in the mitochondrial 12S rRNA gene and is studied mainly for insulin sensitivity, AMPK signaling, and energy metabolism. Humanin is a 24-amino-acid peptide encoded in the 16S rRNA gene and is studied mainly for cell survival, neuroprotection, and resistance to stress-induced apoptosis. They are both mitochondrial-derived peptides, but they serve different signaling roles.
Are MOTS-c and humanin FDA-approved?
No. Neither MOTS-c nor humanin is FDA-approved for human use in the United States. Both are sold as research chemicals labeled for laboratory use only, which means their purity and identity are not regulated. Tesamorelin is the only compound in this general category with an approved human indication.
Can MOTS-c and humanin be taken together?
There is no published human trial testing MOTS-c and humanin together, so their combined safety and effects in people are unknown. Animal and cell studies examine them separately, typically with different protocols and endpoints. Anyone considering combined use should discuss it with a licensed healthcare professional rather than rely on online protocols.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.